Autoantibodies Neutralizing Type I INFs May Be Associated with Efficacy of Tocilizumab in COVID-19 Pneumonia.

ABSTRACT:

SUBMITTER: Chauvineau-Grenier A 

PROVIDER: S-EPMC9177133 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature